Invuity Inc (NASDAQ:IVTY) Director Eric W. Roberts acquired 12,500 shares of the firm’s stock in a transaction that occurred on Friday, June 8th. The stock was bought at an average cost of $3.73 per share, with a total value of $46,625.00. Following the completion of the transaction, the director now directly owns 163,795 shares in the company, valued at $610,955.35. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink.
Invuity traded down $0.05, reaching $3.50, during trading on Thursday, according to MarketBeat Ratings. 18,431 shares of the company’s stock were exchanged, compared to its average volume of 128,075. Invuity Inc has a 1 year low of $2.35 and a 1 year high of $9.55. The company has a current ratio of 3.38, a quick ratio of 2.78 and a debt-to-equity ratio of 2.76. The firm has a market capitalization of $87.75 million, a PE ratio of -1.59 and a beta of -0.01.
Invuity (NASDAQ:IVTY) last posted its quarterly earnings results on Thursday, May 3rd. The medical instruments supplier reported ($0.62) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.52) by ($0.10). Invuity had a negative return on equity of 543.34% and a negative net margin of 94.51%. The business had revenue of $9.51 million for the quarter, compared to analysts’ expectations of $9.58 million. analysts predict that Invuity Inc will post -1.64 EPS for the current fiscal year.
Institutional investors and hedge funds have recently bought and sold shares of the business. Eversept Partners LLC purchased a new position in Invuity during the 4th quarter worth approximately $279,000. Millennium Management LLC raised its position in Invuity by 26.5% during the 4th quarter. Millennium Management LLC now owns 418,116 shares of the medical instruments supplier’s stock worth $2,592,000 after buying an additional 87,587 shares during the last quarter. BlueCrest Capital Management Ltd purchased a new position in Invuity during the 4th quarter worth approximately $139,000. Wells Fargo & Company MN raised its position in Invuity by 987.0% during the 4th quarter. Wells Fargo & Company MN now owns 64,198 shares of the medical instruments supplier’s stock worth $398,000 after buying an additional 58,292 shares during the last quarter. Finally, CVI Holdings LLC purchased a new position in Invuity during the 1st quarter worth approximately $302,000. 63.28% of the stock is owned by institutional investors.
Several brokerages recently commented on IVTY. Zacks Investment Research lowered shares of Invuity from a “buy” rating to a “hold” rating in a research report on Saturday, May 12th. ValuEngine raised shares of Invuity from a “sell” rating to a “hold” rating in a research report on Saturday, June 2nd. Stifel Nicolaus decreased their price objective on shares of Invuity from $6.00 to $5.00 and set a “buy” rating for the company in a research report on Friday, May 4th. Finally, Northland Securities reaffirmed a “buy” rating and issued a $6.00 price objective on shares of Invuity in a research report on Wednesday, February 14th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. Invuity currently has a consensus rating of “Buy” and an average price target of $6.63.
Invuity, Inc, a medical technology company, develops and markets surgical devices in the United States and Asia. The company through its intelligent photonics technology platform develops single-use and reusable illuminated surgical devices, which provide surgeons with illumination and direct visualization of surgical cavities.
Receive News & Ratings for Invuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invuity and related companies with MarketBeat.com's FREE daily email newsletter.